Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07163078 · ClinicalTrials.gov registry record · NA
Nutrition Supplement for Cystic Fibrosis
A NA study, sponsored by Ohio State University.
- Not yet
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07163078: Clinical Trial NA study, sponsored by Ohio State University.
NCT07163078 is a NA study that has not yet begun recruiting, run by Ohio State University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07163078, a NA study, has not yet begun recruiting, sponsored by Ohio State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The goal of this study is to learn if one nutrition supplement formula works better than a different formula in adults with cystic fibrosis. The main question being addressed is: Will certain atypical versions of certain nutrients outperform typical versions of these nutrients? This will be determined by examining blood measures of nutrient levels and/or indications of nutrient function indicators pre- and post-intervention. Participants will take the supplements for 6 weeks with a blood draw before and after that time.
Primary Outcome
Plasma concentrations of 25-OH vitamin D (ng/ml)
Interventions
- DIETARY_SUPPLEMENT Common form supplementation
- DIETARY_SUPPLEMENT Uncommon nutrient supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-01 |
| Phase | NA |
What is known before NCT07163078 opens enrollment
NCT07163078 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Common form supplementation is the first listed.
NCT07163078 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07163078 about?
NCT07163078 is a clinical study titled "Nutrition Supplement for Cystic Fibrosis". The goal of this study is to learn if one nutrition supplement formula works better than a different formula in adults with cystic fibrosis. The main question being addressed is: Will certain atypical versions of certain nutrients outperform typical versions of these nutrients? This will be determin...
What is the current status of trial NCT07163078?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-06. Estimated completion is 2027-01.
What interventions are being tested in trial NCT07163078?
The interventions under investigation include: Common form supplementation (DIETARY_SUPPLEMENT), Uncommon nutrient supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07163078?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07163078's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia